Search results
Godzilla Minus One: What Happened to Noriko? Tattoo on Neck Explained
COMINGSOON.net via Yahoo News· 4 days agoGodzilla Minus One debuted on Netflix on June 1 in several regions across the world, including the...
Stomach cancer risk factors: Age, sex, lifestyle, and more
Medical News Today· 2 days agoRisk factors for stomach cancer include older age, being male, and H. pylori infection. Read about...
This Oscar-Winning Epic Is The Top Movie On Netflix Right Now
HuffPost via Yahoo News· 3 days agoThe 2023 Japanese epic is the 37th film in the Godzilla franchise about a prehistoric reptilian...
Chinese craft lands on moon's far side amid global rivalry in space
Euronews via Yahoo News· 5 days agoEarlier this week, a climate research satellite co-launched by Europe and Japan was sent into orbit....
What is the Mark on Noriko's Neck in Godzilla Minus One?
The Cinemaholic· 4 days agoSet in the aftermath of the Second World War, the focus shifts towards Japan, where Kōichi...
Japan discharges toxic water despite protests
China Daily· 2 days agoThe operator of the crippled Fukushima Daiichi nuclear power plant in Japan completed the sixth round of discharge of nuclear-contaminated water from the facility into the ...
What Was The ‘Demon Core,’ And Why Does It Matter?
Forbes· 2 days agoWhile researching an adventure story this week about scuba-diving the wrecks of warships sunk by nuclear testing in 1946 at the Bikini Atoll - Operation...
JAXA loses contact with sole active Venus probe, Akatsuki
The Register· 4 days agoThe Japan Aerospace Exploration Agency (JAXA) has lost contact with the only active Venus probe,...
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 2 days agoOsimertinib, produced by AstraZeneca under the brand name Tagrisso, significantly extends the time patients live without their cancer worsening, offering the first effective therapy and new ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoGenmab A/S (Nasdaq: GMAB, “Genmab”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced initial data from the ongoing Phase 2 trial (NCT05117242) evaluating acasunlimab (DuoBody-PD-L1x4 ...